International Conference on Oncogenesis and Oncologic Emergency medicine September 17-18, 2018 San Diego, California, USA

Transcription

1 conferenceseries LLC Ltd Tentative Program International Conference on Oncogenesis and Oncologic Emergency medicine September 17-18, 2018 San Diego, California, USA Theme: Research Innovation and Navigating Cancer care Oncogenesis 2018 W: E:

2 Welcome Message Dear Colleagues, Colleen Huber Naturopathic Cancer Society, USA I am honored to welcome you to the International Conference on Oncogenesis & Oncologic Emergency Medicine Conference Series LLC Ltd is at the forefront of exploration of innovative ideas in conference settings. Our vision is to bring together both established and young scientists in a broad range of academic fields. Because these are not typical large institution conferences, we have fielded a refreshingly vast range of philosophy and technique in our conferences. As a result, we have received overwhelmingly positive comments from conference participants. Our main theme this year is Research Innovation and Navigating Cancer Care Which coversfundamental as well as technical levels. Our objective is to explore far-reaching implications of novel techniques in cancer treatment. We hope that all participants will have a productive, inspiring and enjoyable experience To know more about conference series LLC Ltd Visit: With Best Regards, Prof. Colleen Huber Naturopathic Cancer Society, USA

3 Welcome Message Andrei-Gartel University of Illinois at Chicago, USA Dear Colleagues, Welcome you to the International Conference on Oncogenesis and Oncologic Emergency Medicine. The series of conferences has a tradition to explore innovative ideas by bringing together both established and young scientists in the fields. Our main theme this year is Research Innovation and navigating Cancer care which covers fundamental as well as technical levels and explore farreaching implications of novel techniques in oncologic treatment. We hope that all participants will have a productive, inspiring and enjoyable time. With Best Regards, Prof. Andrei-Gartel Associate Professor University of Illinois at Chicago, USA

4 Oncogenesis 2018 Keynotes & OCM Colleen Huber Naturopathic Cancer Society USA Andrei Gartel University of Illinois at Chicago, USA Wassil Nowicky Nowicky pharma Austria Magnus Magnusson University of Iceland Iceland Marja T Nevalainen Medical College of Wiscon USA jie-xu MD Anderson Cancer Center USA Ajit Kumar AIIMS INDIA Sandip-K-Mishra Institute of Life Sciences India W: E: oncogenesis@annualamericacongress.org

5 Best Poster Award You will be given about 5-7 minutes to present your poster including questions and answers. Judges may pose questions during the evaluation of the poster Judges will even evaluate the student s enthusiasm towards their study, interest and knowledge in the area of their research The winners will be announced at the closing ceremony of the conference. The decision of the winner will be withdrawn if the winner/winners is/are not present at the time of announcement Apart from the judging time you may also be present at the poster to share your research with interested delegates Young Researchers Forum Present your research through oral presentations Learn about career development and the latest research tools and technologies in your field This forum will give pertinent and timely information to those who conduct research and those who use and benefit from research Develop a foundation for collaboration among young researchers The forum will provide an opportunity for collegial interaction with other young investigators and established senior investigators across the globe Interact and share ideas with both peers and mentors General Queries oncogenesis@annualamericacongress.org For detailed sessions & sub-sessions, kindly visit: Submit your Abstract Online: Register Online:

6 Featured Speakers Keynote Opportunities Available Keynote Speakers Title: Sugar and cancer: A 7-year, controlled study Colleen Huber, Naturopathic Cancer Society, Arizona, USA Title: Rewiring metabolic and redox networks in cancer as a novel diagnostic and therapeutic strategy Andrei L. Gartel University of Illinois at Chicago, USA Title: Novel small-molecule Stat5 Inhibitor for further optimization and clinical development for cancer therapy Marja T Nevalainen, MD Anderson Cancer Center, USA Title: ZBP-89 and hypoxia-inducible factor 1a in hepatocellular carcinoma Wassil Nowicky, Nowicky Pharma / Ukrainian Anti-Cancer Institute, Austria Title: Expression of programmed cell death 1 ligands in histiocytic and dendritic cell neoplasms Jiexu, Md Anderson, USA Title: Self-similarity and T-patterns from Cell City to the only big-brain mass-societies formed in a recent eye-blink: proteomics as bio-sociology. Magnus S Magnusson, University of Iceland, Reykjavik, Iceland Title: Etiopathology of Wilms Tumor in India - Genetic Heterogeneity and Increasing Risk Factor involving Novel Gene Mutations of MTHFR gene polymorphism. Ajit Kumar Saxena, All India Institute of Medical Sciences, Patna, Bihar, India Title: Epigenetics of Breast Cancer and possible culprits in inducing metastasis in Estrogen Receptor alpha positive Breast Cancer Sandip K Mishra, Institute of Life Sciences, India Featured Speakers Title: Effects of newer anti-cancer agents on the kidney Ketki Tendulkar, University of Nebraska Medical Center, USA Title: The Cancer Revolution A program to reverse and prevent cancer. Leigh Erin Connealy, Center For New Medicine, USA Title: Advance Preoperative Assessment of Cancer patients leads to lower percentage of same day cancellations, increasing positive perioperative patient experience. Katy E French, MD Anderson Cancer Institute, USA Title: Exosomes of Human Melanoma Cells Induce Cancer Development in Human Dermal Cells through Rab27a and c-met Özge Sezin SOMUNCU, Bahçeşehir University., Turkey Title: GanplexTM and Kimera-TestTM: Biotechnological screening tools designed identify human cancer-related virus and SNPs in non-invasive samples. Gisela Aguirre-Gil, Universidad Nacional Autónoma de México., Mexico Title: INDIAN TREATMENT FOR LEUKEMIA AND OTHER CANCERS James Vaidyan, Ayurveda Vaidyasala, Center for Cancer treatment, India Title: Cytotoxic, apoptotic and tumor regressive efficacy of PLGA encapsulated diosgenin nanoparticles in cancer cell lines Sujata Maiti Choudhury, Vidyasagar University, India W: E: oncogenesis@annualamericacongress.org

7 Title: Stability and efficacy of a therapeutic dose of Lu-Dotatate prepared at a remote centralized Radiopharmacy: the initial clinical results [Work in progress] Maharaj Masha, Umhlanga Molecular Imaging and Therapy Centre, South Africa. Title: ORAL MUCOCITIS : A VERY COMMON ORAL SIDE EFFECT OF RADIO-CHEMOTHERAPY Narjiss Akerzoul, Mohammed V University Of Rabat, Morocco, Title: KAPOSI SARCOMA AND HHV8 Narjiss Akerzoul, Mohammed V University Of Rabat, Morocco Title: BURKITT LYMPHOMA: A SUCCESSFUL CHEMO-SENSIBLE MALIGNANT PROCESS Narjiss Akerzoul, Mohammed V University Of Rabat, Morocco Title: Molecular mechanisms involved in acquired chemotherapeutic drug resistance to 5-FU in colorectal cancer Nidhi Abraham, La Trobe UniversityMelbourne, VIC, Australia Title: Overexpression And Roles Of Selective Regulation Of The Axis IL-23 / IL-17 In The Saliva Of Oral Lichen Planus Narjiss Akerzoul, Mohammed V University Of Rabat, Morocco Title: Indole-3-carbinol-mediated biogenic gold nanoparticles provoke cell death by inducing oxidative stress and apoptosis in T cell leukemia and lymphoma Ananya Pradhan, Vidyasagar University, India Title: The role of stemness-gene OCT4 in tamoxifen resistant breast cancer Adesola Badejo, University of Lincoln, UK. Title: A Practical Guide to the Treatment of Melanoma during Pregnancy Sarah J Vitug, Melanoma Institute, Australia Title: GanplexTM and Kimera-TestTM: Biotechnological screening tools designed identify human cancer-related virus and SNPs in non-invasive samples. Elizibeth Meda, Laboratorio de Innovación en Diagnóstico Molecular, México Title: An Integrative Approach with Cannabinoid Analogues Tori Strong, Vyripharm Biopharmaceuticals, USA Title: Genomic analyses reveal FOXO signaling pathway associated with tumorigenesis of Myelodysplastic syndromes (MDS) Jay Zhang, San Valley Biotechnology LLC, USA Title: Acute Flash Pulmonary Edema; Rare Side Effect of Abiraterone Muhammad Idrees, Columbia University, USA Title: Humanizing Cancer Care : The Patient Perspective Brianne Joseph, Sly Fox Investigations, USA Title: IMPLICATING IMMUNOTHERAPY IN MYASTHENIA GRAVIS Blessie Nelson, Sinai Hospital of Baltimore, USA 10 Speaker slots and 2 Keynote slots available Attend the conference along with your group and avail Group Discounts W: E: oncogenesis2018@gmail.com

8 Conference Venue San Diego, USA San Diego Located on the coast of the Pacific Ocean in Southern California, San Diego is widely known as America s Finest City. Famous for its miles and miles of white-sand beaches and amazing weather, the city offers an abundance of fun attractions for visitors of all ages. Boasting a citywide population of more than 1.3 million and more than 3 million residents countywide, San Diego is California s second largest city and the United States eighth largest. San Diego County is made up of 18 incorporate cities and towns along with other charismatic neighborhoods and communities, such as Carlsbad, Coronado, Del Mar, Downtown San Diego s Gaslamp Quarter, Point Loma, Chula Vista, Old Town, La Jolla, and North Park. Discovered in 1542 by European explorer Juan Rodriguez Cabrillo, San Diego was originally named San Miguel. The bay and area of present-day San Diego was given its current name 60 years later, in European settlement in present-san Diego County first began with the founding of the first Catholic mission, Mission San Diego de Alcala, in San Diego is renowned for its incredible climate, which is characterized as warm, dry summers and mild winters with most of the annual precipitation falling between December and March. America s Finest City also showcases many popular attractions for the whole family to enjoy. Some of these include Sea World San Diego, LEGOLAND California, the world-famous San Diego Zoo, the Cabrillo National Monument, Balboa Park, several casinos, and many historic parks and museums. Another attraction of San Diego is its immediacy to Mexico. Because they share an international border, Tijuana and San Diego are grouped together as an international metropolitan area. Many visitors make their way south to enjoy luxury spas, beachfront resorts, golf courses, multicultural festivals and celebrations, colorful neighborhoods, and the nightlife. The city is also home to several major producers of wireless cellular technology, such as Qualcomm and LG Electronics. Because of UCSD and other research institutions, biotechnology & life science has made a large presence in the county. There are more than 400 biotechnology companies in the region alone. The only real question is whether there will be enough time to experience everything this great city has to offer. San Diego will truly be an unforgettable vacation. We look forward to meet you in San Diego!

9 Tourist Attraction in San Diego, USA W: E:

10 Glimpses of Cancer Conferences W: E: